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Abstract
Background: Small dense low-density lipoprotein cholesterol (sdLDL-C) concentration was useful in the assessment
of the presence of cardiovascular diseases (CVD) and its severity. We examined whether SdLDL-C is more closely
associated with carotid artery intima-media thickness (CA-IMT), a surrogate measure of atherosclerosis, than LDL-C
and traditional CVD risk factors in Chinese healthy subjects.
Methods: We measured CA-IMT, blood pressure (BP), sdLDL-C, glucose metabolism and lipid in 183 native Chinese
healthy subjects. CA-IMT was assessed by ultrasonography, and sdLDL-C concentrations were measured by a
homogenous assay. Pearson's correlation coefficient analyses and Multiple regression analyses were used to examine
the relationships between CA-IMT values and other clinical variables.
Results: The sdLDL-C level was significantly higher in males than in females (p <0.05) and there was an age effect on
sdLDL-C (p <0.05). When the effects of age, gender and other traditional CVD risk factors were adjusted using multiple
regression analysis. CA-IMT remained significantly associated with sdLDL-C(β = 0.437, p <0.001).
Conclusions: There are gender and age differences in sdLDL-C levels among a healthy Chinese population. Moreover,
we found adjusted traditional CVD risk factors such as higher age, male sex, and other traditional CVD risk factors, the
association between CA-IMT and SdLDL-C remained significant. sdLDL-C is may be a useful predictor in the assessment
of CA-IMT in Chinese population.
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Background
Low-density lipoprotein (LDL) consists of a continuum
of particles varying in size, density, electrical charge, and
chemical (lipid and apo-protein) composition. LDL was
identified in the density range 1.019–1.060 g/ml, namely
large buoyant LDL (lbLDL), and range 1.034–1.044 g/
ml, namely small dense LDL (sdLDL) [1, 2]. Compared
with lbLDL, small dense LDL cholesterol (sdLDL-C) is
thought to be more atherogenic [3]. Indeed, higher levels
of sdLDL particles are considered to be more athero-
genic compared with lbLDL cholesterol (lbLDL-C) parti-
cles; therefore, sdLDL-C is considered to be an important
and independent predictor of cardiovascular diseases
(CVD) [4–8]. Thus, the selective measurement of sdLDL-
C concentrations is useful for evaluating the actual
atherogenic risk of individuals. The sdLDL is tradition-
ally measured by ultracentrifugation [9] or gradient gel
electrophoresis (GGE) [10] to evaluate the density or
LDL particle size, respectively. However, both methods
are laborious and require special equipment and a long
running time. Nuclear magnetic resonance (NMR) im-
aging is capable of simultaneously determining the size
and number of LDL particles [11]. However, the
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instrumentation required for NMR is too expensive for
general clinical laboratories to acquire feasibly. High
performance liquid chromatography (HPLC) enables
the determination of lipid concentrations in various
lipoprotein subfractions [12]. However, HPLC is also la-
borious, time-consuming, and expensive for routine
clinical use. Hirano et al. [13] have developed a method
that uses heparin sodium salt precipitation followed by
centrifugation for measuring sdLDL-C, and it still re-
quired offline sample pretreatment that hindered its
smooth integration into general clinical use. Recently, a
new fully automated homogenous assay for measuring
sdLDL-C was being used, and sdLDL-C values showed ex-
cellent agreement with the sdLDL isolation by sequential
ultracentrifugation [14]. This precise and rapid method al-
lows for the routine of large number of samples.
Carotid artery intima-media thickness (CA-IMT) has
been utilized as one of the surrogate markers for cardio-
vascular disease in different populations [15, 16]. CA-
IMT increases in high-risk populations such as elderly
people [17], those with hypertension [18], diabetes melli-
tus [19], and chronic kidney disease [20, 21]. Although
several studies have reported an association between
CA-IMTand LDL particle size distribution in the Japanese
and U.S. populations [22–25], it has not been studied in
the Chinese population, especially the healthy Chinese
population. Furthermore, the measurement of sdLDL-C
concentration was useful in the assessment of the pres-
ence of CVD [13, 26] and its severity [24]. In addition, a
recent publication by Arai et al. [27] demonstrated the
utility of the sdLDL-C concentration as a predictive
marker for CVD incidence. Since the etiology of CVD
is complex, involving environmental and genetic factors
that might change from one population to the other, it
is important to assess this association in Chinese popu-
lations. sdLDL-C is may b a useful predictor in the as-
sessment of CA-IMT in Chinese subjects.
The purpose of this study is to evaluate whether the
quantitative measurement of SdLDL-C gives better in-
formation in CVD risk assessment than standard LDL-C
and other lipid variables using CA-IMT as a surrogate
measure of atherosclerosis.
Results
sdLDL-C and various parameters in the study subjects
One hundred eighty-three subjects were classified into
males group and females group. The age of the subjects
ranged from 20 to 78 years old, and the mean age was
45.8 ± 14.6y. Each subject had a normal chemistry and
physical profile, and the subject characteristics are sum-
marized in (Table 1). We found that the males group
had significantly higher BMI, Systolic BP, TC, sdLDL-C
levels than females group (p <0.05), and had significantly
lower HDL-C level than females group (p <0.05).
sdLDL-C in the healthy subjects
We compared the frequency distribution of sdLDL-C
among females and males first (Fig. 1) and then sepa-
rated the healthy female and male population into five
age groups (Fig. 2) in order to determine whether there
was an age or a gender difference. We found that there
was an age effect on sdLDL-C in both males and fe-
males. The sdLDL-C level was significantly higher in
males above 50 years old than those below 50 years old
(16.4 ± 4.1 vs 13.3 ± 3.2 mg/dl, p <0.01). Females above
40 years old had a higher sdLDL-C level than those below
40 years old (14.4 ± 3.9 vs 12.1 ± 3.0 mg/dl, p <0.01). The
percentiles of sdLDL-C value are summarized in (Table 2).
Correlation between sdLDL-C and CA-IMT
The results of the Pearson's correlation coefficient ana-
lyses revealed that CA-IMT was positively correlated with
age (r = 0.770, p <0.001), systolic BP (r = 0.398, p <0.001),
diastolic BP (r = 0.343, p <0.001), fasting plasma glucose
(r = 0.261, p <0.001), HbA1c (r = 0.192, p = 0.009), total
cholesterol (r = 0.202, p =0.006), triglycerides (r = 0.226,
p = 0.002), LDL cholesterol (r = 0.340, p <0.001), non-
HDL cholesterol (r = 0.149, p = 0.044), large buoyant LDL
cholesterol (r = 0.182, p = 0.014), and sdLDL-C (r = 0.436,
p <0.001), but had no significant association with other
clinical variables (Table 3). The results of the multiple
Table 1 Subject characteristics
Variable Male Female P
n 95 88 –
Age (year) 47.31 ± 14.58 44.20 ± 14.62 0.153
BMI (kg/m2) 23.65 ± 3.61 22.64 ± 3.32 0.042
Systolic BP (mm Hg) 117.37 ± 12.23 113.15 ± 10.80 0.015
Diastolic BP (mm Hg) 83.23 ± 6.34 81.81 ± 5.26 0.088
Family CVD events 43/95 39/88 0.898
FBG (mg/dl) 88.41 ± 7.89 88.87 ± 8.12 0.701
HbA1c (%) 5.34 ± 0.93 5.18 ± 0.87 0.232
TG (mg/dl) 88.83 ± 28.91 82.86 ± 27.89 0.157
TC (mg/dl) 167.94 ± 18.66 161.38 ± 18.55 0.018
HDL-C (mg/dl) 48.43 ± 9.61 54.81 ± 9.64 <0.001
Non- HDL-C (mg/dl) 112.96 ± 15.16 113.13 ± 15.12 0.939
LDL-C (mg/dl) 96.71 ± 12.14 96.72 ± 12.25 0.994
LbLDL-C (mg/dl) 83.23 ± 11.93 82.92 ± 11.69 0.858
SdLDL-C (mg/dl) 14.1 ± 3.9 13.2 ± 3.1 0.041
CA-IMT (mm) 0.54 ± 0.13 0.52 ± 0.14 0.154
Continuous and categorical variables data are expressed as the mean ±
standard deviations and real number of subjects, respectively. Means were
compared between male and female groups by Student’s t-test. The χ-square
test was employed to compare Family CVD events distribution
Abbreviation: BMI body mass index, BP blood pressure, FBG fasting blood
glucose, HbAlc hemoglobin A1c, TG triglyceride, TC total cholesterol, HDL-C
high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol,
lbLDL-C large buoyant LDL-C, SdLDL-C small dense LDL-C, CA-IMT carotid artery
intima-media thickness LbLDL-C (mg/dl) = LDL-C (mg/dl) − SdLDL-C (mg/dl)
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regression analysis: First: sdLDL-C as an independent
variable adjusted for age and sex revealed that dependent
CA-IMT determinants remained significantly associated
with sdLDL-C; Second: adjustment for Family CVD his-
tory, smoking, systolic BP, diastolic BP, FBG, HbA1c, TC,
HDL-C, TC, LDL-C, non-HDL cholesterol, large buoyant
LDL cholesterol, and sdLDL-C revealed that dependent
CA-IMT determinants remained significantly associated
with sdLDL-C (Table 4).
Discussion
In this study, we observed that there are gender and age
differences in sdLDL-C levels among our tested popula-
tion, consistenting with the data obtained in the Western
populations [26, 28]. Although we have not separated
menopausal and premenopausal women, women above
40 years old had a higher sdLDL-C concentration than
those below 40 years old. Several studies have consistently
shown more favorable lipoprotein profiles among premen-
opausal women than among men due to estrogen-related
protective mechanisms [29, 30]. It is well known that
CVD risk markedly increases with aging in men and
menopausal women, and alterations in LDL clearly con-
tribute to this increased risk [31].
Moreover, we compared the associations of CA-IMT
with SdLDL-C, LDL-C and other various risk factors for
CVD in 183 healthy Chinese population. In univariate
analysis, CA-IMT was most closely associated with
SdLDL-C among the variables tested. This was also true
when the effects of age, gender and other traditional
CVD risk factors were adjusted using multiple regression
analysis. These results suggest that SdLDL-C is a quanti-
tative risk marker of CVD that is more closely associated
with CA-IMT than the standard lipid parameters in
healthy Chinese population.
Previous studies [22, 24, 25] showed that an association
between CA-IMT and sdLDL-C concentrations measured
by other methods. Using GGE, Skoglund-Andersson et al.
[22] found that plasma concentration of the predominant
sdLDL-C subfraction correlated strongly with common
CA-IMT in healthy 50-year-old men. Shoji et al. [24] re-
ported that CA-IMT was strongly correlated with
sdLDL-C in subjects with dyslipidemia, diabetes melli-
tus, hypertension, and chronic kidney disease, as well
Fig. 1 The frequency distribution of small dense low-density lipoprotein
cholesterol (sdLDL-C) of healthy males and females with normolipidemia
Fig. 2 Normal small dense low-density lipoprotein cholesterol (sdLDL-C)
concentrations in various age groups and in males and female
Table 2 The percentiles of sdLDL-C value
Variable sdLDL-C (mg/dl)
P25 P50 P75 P95
All subjects 10.3 12.5 15.7 21.0
Males 10.6 12.9 16.1 21.6
Females 9.3 12.3 15.6 20.6
Abbreviations are the same as those for Table 1
Table 3 Correlation between CA-IMT values and sdLDL-C values
and other variables
Variable r P value
Age 0.770 <0.001
BMI 0.106 0.153
Systolic BP 0.398 <0.001










Pearson's correlation coefficient analyses were used to explore the relationships
Abbreviations are the same as those for Table 1
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as in smokers by simple precipitation methods. Using
NMR, Maeda et al. [25] showed that, compared with
TC and LDL-C, abnormalities in HDL-C and sdLDL-C
were more strongly and consistently associated with
common CA-IMT in patient with moderate chronic
kidney disease. In the present study we measured CA-
IMT as one of the surrogate markers of atherosclerosis,
and found that CA-IMT was more closely associated
with SdLDL-C than other lipid parameters tested in
healthy Chinese population.
The key finding of this study was that SdLDL-C was a
better lipid variable than other standard parameters in
assessing the risk of CVD using CA-IMT in healthy
population. There are several explanations for this find-
ing. First, SdLDL-C was associated with CA-IMT due
simply to its increased level in other traditional CVD
risk factors. In fact, we found adjusted traditional CVD
risk factors such as higher age, male sex, smoking and
Family CVD history, the association between CA-IMT
and SdLDL-C remained significant. Therefore, although
SdLDL-C is interrelated with other coronary risk factors,
such relations do not fully explain the superior associ-
ation of SdLDL-C with CA-IMT. Second, sdLDL is
higher susceptibility to oxidation, and oxidized LDL in-
duces smooth muscle cell proliferation [32], therefore,
sdLDL are more atherogenic [33]. sdLDL may initiate
the development of carotid atherosclerosis, and we
speculate that sdLDL-C concentrations may have a close
relationship with CA-IMT.
The present study has some limitations. First, the co-
hort was relatively small. Second, only the healthy sub-
jects enrolled in the present study. Subjects with
coronary risk factors or CVD are required. Finally, being
a cross-sectional study, it is not possible to determine a
cause and effect relationship between sdLDL-C concen-
trations and CA-IMT. Further studies are needed to
clarify whether CA-IMT is with sdLDL-C concentra-
tions, as measured by homogenous assay, in subjects
with coronary risk factors or CVD.
Conclusion
We observed that there are gender and age differences
in sdLDL-C levels among a healthy Chinese population.
Moreover, we found adjusted traditional CVD risk fac-
tors such as higher age, male sex, smoking and Family
CVD history, the association between CA-IMT and
SdLDL-C remained significant. sdLDL-C is may be a use-




One hundred eighty-three healthy subjects were ran-
domly collected from consecutive subjects visiting The
First People's Hospital of Wujiang, for an annual health
checkup from April 2014 to April 2015. The including
criteria were: 1) All subjects were native Chinese, and re-
quired to have lived in Suzhou since birth. 2) The age
should be more than 20 years old. 3) We excluded all
subjects with a history of CVD, thromboembolic disease
or congestive heart failure; peripheral arterial disease;
malignancy; infectious disease; liver or renal disease;
overt endocrine disease. In addition, subjects with hyper-
tension, dyslipidemia, diabetes mellitus, as defined by
the diagnostic criteria [31, 34, 35] were not included.
None of the healthy subjects were currently taking any
medications that could influence glycemic and lipid.
All subjects were divided into female group, male
group and 5 age groups (20–29, 30–39, 40–49, 50-59,
and ≥60 years old). Comparisons of mean values of
CA-IMT, BP, sdLDL-C, glucose metabolism and lipid
between both males and females, and sdLDL-C concen-
trations in various age groups and in males and females
by Student’s t-test. The height and weight of subjects
were measured and the body mass index (BMI, weight
in kilograms divided by height in meters squared) was
calculated. BP was measured in the morning (after a
12 h fast) by the same investigator with a sphygmoman-
ometer on the right arm of the subject after a 10-min
rest in the supine position. We performed physical ex-
aminations and CA-IMT examinations in the morning
(after a 12 h fast) and obtained blood samples from the
antecubital vein for serum and plasma analyses at the
same time. This study was approved by the local ethics
committee and was carried out according to the princi-
ples of the Declaration of Helsinki. Each subject pro-
vided informed consent.
Table 4 Multivariate associations of CA-IMT with SdLDL-C and
other parameters adjusted by age and sex
Variable Model 1 Model 2
β P β P
Age 0.562 <0.001 0.422 <0.001
Sex (Male vs. Female) −0.116 0.269 −0.132 0.067
Family CVD history (Yes vs No) 0.313 <0.001
BMI 0.105 0.155
Smoking (Smokers vs non-smokers) 0.156 0.021
Systolic BP (mm Hg) 0.298 <0.001
Diastolic BP (mm Hg) 0.287 <0.001
FBG (mg/dl) 0.098 0.252
Log TC (mg/dl) 0.052 0.478
HDL-C (mg/dl) 0.061 0.450
LDL-C (mg/dl) 0.123 0.084
SdLDL-C (mg/dl) 0.406 <0.001 0.437 <0.001
Abbreviations are the same as those for Table 1
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Carotid ultrasonography
A trained technicians who was blinded to the clinical
characteristics of subject groups evaluated the wall thick-
ness of the carotid arteries in all participants using high-
resolution B-mode ultrasound (Philips iU22 ultrasound
System) equipped with a L9-3 (7.5 MHz) linear array
transducer (Philips Healthcare, Best, The Netherlands)
[36]. After the subject had rested for at least 10 min in the
supine position with the neck in slight hyperextension, we
evaluated the optimal visualization of the common ca-
rotid arteries, carotid bulb, and extracranial internal
and external carotid arteries bilaterally. CA-IMT was
assessed as the greatest CA-IMT at any location in the
far walls of these carotid arteries on both sides. The
max CA-IMT was defined as the greater of the 2 unilat-
eral CA-IMT values [37].
Laboratory measurements
Fasting blood glucose (FBG), Total cholesterol (TC),
Triglyceride (TG), High-density lipoprotein cholesterol
(HDL-C), and LDL cholesterol (LDL-C) were measured
by standard laboratory procedures. An automatic bio-
chemistry analyzer (Hitachi-7600; Hitachi, Tokyo, Japan)
was used for all above tests, using standard kits.
Hemoglobin A1c (HbA1c) level was determined by
HPLC, using automatic analyzer (ADAMS A1c HA-
8181, Arkray). The value of HbA1c (%) was estimated
as a National Glycohemoglobin Standardization Pro-
gram (NGSP) equivalent value (%) derived from the
Japanese Diabetes Society (JDS) value and calculated by
the formula HbA1c (%) = HbA1c (JDS) (%) +0.4 % [38].
The sdLDL-C was measured using a newly developed
homogenous assay in an automatic analyzer (Hitachi-
7600; Hitachi, Tokyo, Japan), and commercial kit
(sdLDL-C, SEIKEN; Denka Seiken, Tokyo, Japan) was
used for determination as we previously reported [39].
Statistical analysis
Continuous data are presented as mean ± SD, and com-
parisons by Student’s t-test. The χ-square test was
employed to compare categorical data. The difference
in frequency data was determined by Chi-squared test.
Pearson's correlation coefficient analyses were used to
explore the relationships between CA-IMT values and
sdLDL-C values and other clinical variables. Multiple
regression analysis was performed using CA-IMT values,
sdLDL-C values, and those of the other clinical variables.
All the probability values were 2-tailed and differences
with P <0.05 were considered to be statistically significant.
All tests were performed by SPSS program version 20.0.
Abbreviations
BMI: body mass index; BP: blood pressure; CA-IMT: carotid artery intima-
media thickness; CVD: cardiovascular diseases; GGE: gradient gel
electrophoresis; HbAlc: hemoglobin A1c; HDL: high-density lipoprotein; HDL-
C: HDL cholesterol; HPLC: high performance liquid chromatography;
lbLDL: large buoyant LDL; LDL: low-density lipoprotein; LDL-C: LDL
cholesterol; NMR: nuclear magnetic resonance; sdLDL: small dense LDL;
sdLDL-C: small dense low-density lipoprotein cholesterol; TC: total
cholesterol; TG: triglyceride.
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